Autobio Diagnostics has released its 2026 interim report, showing net profit attributable to the parent company of 497 million yuan, a decrease of 12.94% compared with the same period last year. Total operating revenue was 2.058 billion yuan, a slight decline of 0.12% year on year. Net cash inflow from operating activities was 216 million yuan, down 47.38% year on year. The latest asset-liability ratio was 25.60%, gross margin was 67.25%, and diluted earnings per share was 0.87 yuan.
Autobio Diagnostics Co LtdNet profit down 12.94% YoY, operating cash flow down 47.38%